Killer cell immunoglobulin‐like receptor (KIR) gene contents: Are they associated with cervical cancer?

• Published in: Journal of medical virology 2023-01, Vol.95 (1), p.e27873-n/a
• Main Authors: Tembhurne, Alok K., Maheshwari, Amita, Warke, Himangi, Chaudhari, Hemangi, Kerkar, Shilpa C., Deodhar, Kedar, Rekhi, Bharat, Mania‐Pramanik, Jayanti
• Format: Article
• Language: English
• Subjects: Biomarkers; Cancer; Cervical cancer; Cervix; Female; Gene Frequency; Genes; Genetic Predisposition to Disease; Genotype; Genotyping; Haplotypes; High frequencies; Human papillomavirus; Humans; Immunoglobulins; Infections; Killer cell immunoglobulin-like receptors; killer cell immunoglobulin‐like receptor; KIR protein; natural killer cell; Natural killer cells; Papillomavirus Infections - complications; Papillomavirus Infections - genetics; Polymerase chain reaction; Polymorphism, Genetic; Potassium channels (inwardly-rectifying); Receptor mechanisms; Receptors; Receptors, KIR - genetics; Receptors, KIR2DL5 - genetics; Tumor cells; Uterine Cervical Neoplasms - genetics; Virology; Viruses
• ISSN: 0146-6615; 1096-9071
• DOI: 10.1002/jmv.27873

Killer cell immunoglobulin‐like receptors (KIRs) are required for natural killer cell function against virus‐infected cells or tumor cells. KIR gene content polymorphisms in Indian women with cervical cancer (CaCx) remain unexplored. Hence, we analyzed the frequencies of KIR genes, KIR haplotypes, and Bx subsets to draw their association with CaCx. The polymerase chain reaction‐sequence‐specific primer method was used for KIR genotyping in three groups of women: healthy controls (n = 114), women with human papillomavirus (HPV) infection (n = 70), and women with CaCx (n = 120). The results showed that the frequency of KIR2DS5 was significantly higher in women with CaCx compared to women with HPV infection (p = 0.02) and healthy controls (p = 0.01). Whereas the frequency of KIR2DL5B was significantly higher in healthy controls than in women with HPV infection (p = 0.02). The total number of activating KIR genes was higher in women with CaCx than in healthy controls (p = 0.006), indicating their positive association with CaCx. Moreover, the C4T4 subset was higher in women with CaCx than in women with HPV infection, though not significant. In conclusion, our findings highlight KIR2DS5, the C4T4 subset, and activating KIR genes are susceptible factors or positively associated with CaCx. Besides KIR2DL5B, this study also reported for the first time significantly high frequency of KIR2DL1 in healthy controls, indicating its possible protective association against CaCx. Further, significantly high frequency of KIR2DL3 observed in HPV‐infected women might be also a promising biomarker for viral infections. Thus, the study confirms the association of KIR genes with cervical cancer in women with HPV infection.